07:57 AM EDT, 04/02/2024 (MT Newswires) -- Acorda Therapeutics' ( ACOR ) shares slumped 76% Tuesday premarket after saying it signed a deal to sell substantially all its assets and that it initiated Chapter 11 bankruptcy proceedings.

Verve Therapeutics ( VERV ) shares fell 34% after the company said it has decided to pause enrollment in its Heart-1 clinical trial after it observed "laboratory abnormalities" in one participant.

PVH Corp. ( PVH ) shares retreated 22% after the company warned of lower revenue for 2024.

Price: 3.24, Change: -10.08, Percent Change: -75.68